The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

All News

Microbiotica Announces Impressive Results in its Phase 1b Trial of MB310 in Ulcerative Colitis
Editor's Choice

Microbiotica Announces Impressive Results in its Phase 1b Trial of MB310 in Ulcerative Colitis

FEB 11, 2026
Researchers Discover that Vaginal Bacteria Don’t Always Behave the Same Way
Pharma & Human Health

Researchers Discover that Vaginal Bacteria Don’t Always Behave the Same Way

FEB 5, 2026
Immunity as a Lifestyle Priority
Editor's Choice

Immunity as a Lifestyle Priority

JAN 30, 2026
‘GABA Factory’ Probiotic LP815® Improves Sleep and Reduces Stress
Biotics and Supplements

‘GABA Factory’ Probiotic LP815® Improves Sleep and Reduces Stress

JAN 22, 2026
EnteroBiotix announces positive Phase 2 results for potential first-in-class, oral, full-spectrum microbiome therapy for IBS
Clinical & Manufacturing

EnteroBiotix announces positive Phase 2 results for potential first-in-class, oral, full-spectrum microbiome therapy for IBS

JAN 8, 2026
AOB Pharma receives EMA positive decision on the Pediatric Investigation Plan for development of B244
Pharma & Human Health

AOB Pharma receives EMA positive decision on the Pediatric Investigation Plan for development of B244

DEC 9, 2025
UC San Diego researchers develop new tool to predict how bacteria influence health
Pharma & Human Health

UC San Diego researchers develop new tool to predict how bacteria influence health

NOV 28, 2025
Traces of bacteria inside brain tumors may affect tumor behavior
Gut-Brain Axis

Traces of bacteria inside brain tumors may affect tumor behavior

NOV 24, 2025
Whitepaper: Oral Drug Delivery of Live Biotherapeutics: From Development to Clinical Trial with EUDRACAP® Select
Clinical & Manufacturing

Whitepaper: Oral Drug Delivery of Live Biotherapeutics: From Development to Clinical Trial with EUDRACAP® Select

NOV 19, 2025
Siolta Therapeutics Reports Positive Phase 2 Results from the ADORED Study
Clinical & Manufacturing

Siolta Therapeutics Reports Positive Phase 2 Results from the ADORED Study

NOV 17, 2025
The OMNIgene™•VAGINAL device – Optimized solutions for vaginal microbiome studies
Editor's Choice

The OMNIgene™•VAGINAL device – Optimized solutions for vaginal microbiome studies

NOV 12, 2025